Connection

MIEN-CHIE HUNG to Tumor Cells, Cultured

This is a "connection" page, showing publications MIEN-CHIE HUNG has written about Tumor Cells, Cultured.
Connection Strength

1.300
  1. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020 10; 22(10):1264-1275.
    View in: PubMed
    Score: 0.111
  2. EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma. Cancer Res. 2019 02 15; 79(4):819-829.
    View in: PubMed
    Score: 0.099
  3. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res. 2010 Jun 15; 70(12):5096-108.
    View in: PubMed
    Score: 0.055
  4. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol. 2006 Oct; 26(19):7269-82.
    View in: PubMed
    Score: 0.042
  5. AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. Mol Cancer Ther. 2006 Jan; 5(1):1-7.
    View in: PubMed
    Score: 0.040
  6. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell. 2005 Jul 22; 19(2):159-70.
    View in: PubMed
    Score: 0.039
  7. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell. 2004 Nov; 6(5):459-69.
    View in: PubMed
    Score: 0.037
  8. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer. Cancer Gene Ther. 2004 Sep; 11(9):594-602.
    View in: PubMed
    Score: 0.037
  9. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell. 2004 Sep; 6(3):251-61.
    View in: PubMed
    Score: 0.037
  10. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 2004 Apr 16; 117(2):225-37.
    View in: PubMed
    Score: 0.036
  11. Delivery of DNA to tumor cells using cationic liposomes. Methods Mol Biol. 2004; 245:125-36.
    View in: PubMed
    Score: 0.035
  12. Prostate-specific antitumor activity by probasin promoter-directed p202 expression. Mol Carcinog. 2003 Jul; 37(3):130-7.
    View in: PubMed
    Score: 0.034
  13. The adenoviral E1A induces p21WAF1/CIP1 expression in cancer cells. Biochem Biophys Res Commun. 2003 Jun 13; 305(4):1099-104.
    View in: PubMed
    Score: 0.034
  14. Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics. Adv Sci (Weinh). 2023 06; 10(16):e2206603.
    View in: PubMed
    Score: 0.033
  15. Expression profile of tyrosine kinases in breast cancer. Clin Cancer Res. 2002 Feb; 8(2):361-7.
    View in: PubMed
    Score: 0.031
  16. Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis. Oncogene. 2002 Jan 03; 21(1):44-52.
    View in: PubMed
    Score: 0.031
  17. Systemic tumor suppression by the proapoptotic gene bik. Cancer Res. 2002 Jan 01; 62(1):8-12.
    View in: PubMed
    Score: 0.030
  18. Transcriptional upregulation and activation of p55Cdc via p34(cdc2) in Taxol-induced apoptosis. Oncogene. 2001 May 03; 20(20):2537-43.
    View in: PubMed
    Score: 0.029
  19. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 2000 Dec 15; 60(24):6841-5.
    View in: PubMed
    Score: 0.028
  20. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 2000 May 11; 19(20):2398-403.
    View in: PubMed
    Score: 0.027
  21. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 2019 09; 68(9):1653-1666.
    View in: PubMed
    Score: 0.025
  22. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene. 1999 Jan 21; 18(3):807-11.
    View in: PubMed
    Score: 0.025
  23. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo. Oncogene. 1998 Oct 29; 17(17):2167-75.
    View in: PubMed
    Score: 0.024
  24. Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene. 1998 Jun 04; 16(22):2855-63.
    View in: PubMed
    Score: 0.024
  25. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol. Oncogene. 1998 Apr 23; 16(16):2087-94.
    View in: PubMed
    Score: 0.024
  26. Inhibition of intratracheal lung cancer development by systemic delivery of E1A. Oncogene. 1996 Oct 03; 13(7):1405-12.
    View in: PubMed
    Score: 0.021
  27. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene. 1996 Sep 19; 13(6):1359-65.
    View in: PubMed
    Score: 0.021
  28. Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL. Cancer Res. 2016 07 01; 76(13):3916-28.
    View in: PubMed
    Score: 0.021
  29. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene. 1996 Feb 01; 12(3):571-6.
    View in: PubMed
    Score: 0.020
  30. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat Commun. 2016 Jan 19; 7:10180.
    View in: PubMed
    Score: 0.020
  31. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. Oncogene. 1995 Oct 05; 11(7):1383-8.
    View in: PubMed
    Score: 0.020
  32. De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells. Oncotarget. 2014 Nov 15; 5(21):10558-70.
    View in: PubMed
    Score: 0.019
  33. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer. Ann Surg Oncol. 2015 Mar; 22(3):889-98.
    View in: PubMed
    Score: 0.018
  34. Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation. Mol Cell. 2014 Jun 19; 54(6):960-974.
    View in: PubMed
    Score: 0.018
  35. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. Cancer Res. 2013 Nov 01; 73(21):6516-25.
    View in: PubMed
    Score: 0.017
  36. The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells. Lasers Med Sci. 2013 Feb; 28(2):605-14.
    View in: PubMed
    Score: 0.016
  37. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells. Mol Cancer Res. 2009 Apr; 7(4):592-600.
    View in: PubMed
    Score: 0.013
  38. Kr?ppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res. 2007 Aug 01; 67(15):7184-93.
    View in: PubMed
    Score: 0.011
  39. Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer. Int J Cancer. 2006 Feb 15; 118(4):802-11.
    View in: PubMed
    Score: 0.010
  40. Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells. Clin Cancer Res. 2004 Oct 15; 10(20):7031-42.
    View in: PubMed
    Score: 0.009
  41. beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecol Oncol. 2003 Mar; 88(3):363-8.
    View in: PubMed
    Score: 0.008
  42. External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator. Proc Natl Acad Sci U S A. 2002 Oct 01; 99(20):12747-52.
    View in: PubMed
    Score: 0.008
  43. Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene. 2002 Sep 12; 21(41):6278-88.
    View in: PubMed
    Score: 0.008
  44. Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene. 2002 Aug 08; 21(34):5224-32.
    View in: PubMed
    Score: 0.008
  45. Inhibition of cancer cell growth by BRCA2. Cancer Res. 2002 Mar 01; 62(5):1311-4.
    View in: PubMed
    Score: 0.008
  46. Localizing the EGF receptor. Nat Cell Biol. 2002 Feb; 4(2):E22; author reply E22-3.
    View in: PubMed
    Score: 0.008
  47. Adenovirus-mediated N5 gene transfer inhibits tumor cell proliferation by induction of apoptosis. Cancer Gene Ther. 2000 Jul; 7(7):985-90.
    View in: PubMed
    Score: 0.007
  48. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene. 1999 Nov 25; 18(50):7034-45.
    View in: PubMed
    Score: 0.007
  49. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene. 1999 Feb 11; 18(6):1325-32.
    View in: PubMed
    Score: 0.006
  50. Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression. Oncogene. 1998 Nov 05; 17(18):2377-81.
    View in: PubMed
    Score: 0.006
  51. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene. 1998 Apr 09; 16(14):1839-49.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.